That study also reported that the therapy lowered the risk of the cancer spreading to other sites by 59% compared to the checkpoint inhibitor alone. https://time.com/article/2026/10/22/moderna-merck-immunotherapy-lowers-melanoma-recurrence/?utm_source=twitter&utm_medium=social&utm_campaign=editorial&utm_content=231026